1
Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A
Condition(s):Severe Hemophilia A Without InhibitorLast Updated:March 16, 2022Active, not recruiting
Hemophilia A: 828 Clinical Trials, Page 1 of 83
Hide Studies Not Open or Pending
2
Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A
Condition(s):Severe Haemophilia ALast Updated:February 23, 2018Completed
3
An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment
Condition(s):Severe Hereditary Factor VIII Deficiency Disease Without Inhibitor; Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor; Haemophilia ALast Updated:May 5, 2022Completed
4
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
Condition(s):Hemophilia ALast Updated:June 16, 2022Recruiting
5
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
Condition(s):Hemophilia ALast Updated:March 27, 2019Completed
6
A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A
Condition(s):Hemophilia ALast Updated:September 23, 2020Recruiting
7
Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:March 17, 2021Completed
8
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq
Condition(s):Hemophilia ALast Updated:February 23, 2021Terminated
9
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
Condition(s):Hemophilia A; Factor VIIILast Updated:April 20, 2022Recruiting
10
Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast
Condition(s):Hemophilia ALast Updated:May 4, 2022Recruiting